Episode Details

Novo Nordisk drops Extensior, a 15% cheaper version of Ozempic, launching July 31st in South Africa — the first registered alternative, though generics are coming. While the discount helps out-of-pocket patients, experts question if it’s enough to sway medical schemes. Both drugs contain semaglutide, used for diabetes and weight loss. A four-week pen costs ~R1,222 vs. Ozempic’s R1,437. Novo says pricing will fall as competition grows, aiming to boost access — including in public healthcare. SA’s regulator has already approved one Indian generic and is reviewing 12 more, promising a more competitive market soon.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/e4284962f95d4e55